跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
劉 明哲
副教授
,
牙體技術學系
合聘副教授
,
臨床醫學研究所
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學泌尿腎臟研究中心
https://orcid.org/0000-0001-5127-7593
電子郵件
d204097002
tmu.edu
tw
h-index
251
引文
9
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2022
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(24)
類似的個人檔案
(6)
如果您對這些純文本內容做了任何改變，很快就會看到。
指紋
查看啟用 Ming-Che Liu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine & Life Sciences
4-acetylantroquinonol B
53%
Acupuncture Points
29%
Aldo-Keto Reductase Family 1 Member C3
46%
Aluminum Hydroxide
32%
Bone Regeneration
26%
Castration
27%
Catenins
59%
Cell Line
37%
Cisplatin
26%
Congenital bilateral aplasia of vas deferens
38%
Cordyceps
36%
cyclopamine
25%
Diterpenes
31%
Electroacupuncture
30%
Erectile Dysfunction
27%
Hedgehog Proteins
37%
Hedgehogs
31%
Hernia
25%
Herniorrhaphy
26%
HhAntag691
38%
Humoral Immunity
32%
hylan
41%
Inactivated Vaccines
29%
Influenza Vaccines
26%
Inguinal Hernia
27%
Intervertebral Disc
27%
Lithotripsy
28%
Maintenance
33%
maxacalcitol
41%
Mesenchymal Stem Cells
27%
Neoplasms
38%
Neoplastic Stem Cells
25%
Nucleus Pulposus
30%
ovatodiolide
100%
Platelet-Rich Plasma
34%
Prostatic Neoplasms
37%
Randomized Controlled Trials
31%
Safety
27%
SARS Virus
57%
Seawater
30%
Secondary Hyperparathyroidism
29%
Seminal Vesicles
28%
Stromal Cells
25%
Taiwan
50%
Therapeutics
26%
Ureter
25%
Urinary Bladder Neoplasms
58%
Vaccines
59%
Vas Deferens
29%
Chemical Compounds
Adipogenic
40%
Adjuvant
9%
Advanced Glycation End-Product
16%
Androgen
14%
Angiogenic
11%
Antidiabetic Agent
14%
Antiinflammatory
18%
Biomaterial
13%
Blood Analysis
17%
Calcium(0)
14%
Cell Marker
38%
Cholesterol
10%
Cisplatin
34%
Cord
29%
Creatinine
14%
Cytometry
12%
D Dimer
38%
Dehydration
19%
Dialysis
23%
Dose
9%
Drug
12%
Environment
13%
Glucose
17%
Growth Factor
9%
Hyaluronic Acid
27%
Hydroxychloroquine
13%
Lipopolysaccharide
17%
Lysine
11%
Marker
58%
Maxacalcitol
49%
Molecule
12%
Neurogenic
13%
Nitrogen Oxide
28%
Oncogenic
11%
Osteogenic
30%
Oxidative Stress
23%
Parathyroid Hormone
27%
Pharmacokinetics
14%
Plasma
29%
Polarization
11%
Proliferative
26%
Protein
25%
Proteoglycan
29%
Renoprotective
22%
Resistance
19%
Signalling Molecule
29%
Simulation
14%
Time
13%
Triglyceride
12%
Weight
21%
Agriculture & Biology
adjuvants
24%
advanced glycation end products
8%
androgen receptors
6%
animal models
5%
antibodies
5%
antibody formation
5%
blood glucose
12%
cell lines
17%
Cordyceps militaris
35%
creatinine
6%
cytoskeleton
5%
diabetic nephropathy
40%
dosage
7%
drug therapy
5%
fibrosis
7%
fruiting bodies
6%
glycemic effect
7%
hemagglutinins
11%
high fat diet
6%
Human papillomavirus type 16
7%
hyaluronic acid
26%
hyperglycemia
14%
hyperplasia
20%
hypoglycemic agents
7%
immunogenicity
27%
inactivated vaccines
30%
inflammation
21%
influenza
6%
influenza vaccines
35%
interleukin-1
5%
interleukin-6
5%
interleukin-8
5%
kidneys
16%
long term effects
5%
mice
13%
mycelium
5%
nicotinamide
7%
nitrogen oxides
12%
preserves
22%
prostaglandin synthase
5%
renal function
28%
risk factors
5%
streptozotocin
7%
stromal cells
29%
therapeutics
7%
Toll-like receptor 4
7%
transforming growth factors
7%
urinary tract diseases
6%
vaccines
20%
vimentin
6%
